相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonalcoholic Steatohepatitis: Current Thinking From the Division of Hepatology and Nutrition at the Food and Drug Administration
Frank A. Anania et al.
HEPATOLOGY (2021)
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis
Ali Aminian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
Guillaume Lassailly et al.
GASTROENTEROLOGY (2020)
Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux -en -Y gastric bypass surgery in diet-induced obese mice
Kun Li et al.
MOLECULAR METABOLISM (2020)
Safety and Efficacy of Bariatric Surgery in Advanced Liver Fibrosis
Aashir Kaul et al.
OBESITY SURGERY (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery
Judith Aron-Wisnewsky et al.
GUT (2019)
Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study
Debashis Haldar et al.
JOURNAL OF HEPATOLOGY (2019)
Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
Jean Debedat et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
Yung Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery
Vance L. Albaugh et al.
GASTROENTEROLOGY (2019)
Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials
Elizabeth M. Brunt et al.
HEPATOLOGY (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large US Claims Database
Alina M. Allen et al.
HEPATOLOGY (2018)
A critical review of endpoints for non-cirrhotic NASH therapeutic trials
Vlad Ratziu
JOURNAL OF HEPATOLOGY (2018)
Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study
Anita P. Courcoulas et al.
JAMA SURGERY (2018)
Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance
Jean Debedat et al.
DIABETES CARE (2018)
The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass
Judith Aron-Wisnewsky et al.
DIABETOLOGIA (2017)
Development and Validation of a Noninvasive Prediction Model for Nonalcoholic Steatohepatitis Resolution After Lifestyle Intervention
Eduardo Vilar-Gomez et al.
HEPATOLOGY (2016)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Guillaume Lassailly et al.
GASTROENTEROLOGY (2015)
Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease
Pierre Bedossa
HEPATOLOGY (2014)
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
M. Fried et al.
OBESITY SURGERY (2014)
The importance of the gut microbiota after bariatric surgery
Judith Aron-Wisnewsky et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice
Thomas A. Wadden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
How Do We Define Cure of Diabetes?
John B. Buse et al.
DIABETES CARE (2009)
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
Philippe Mathurin et al.
GASTROENTEROLOGY (2009)
Bariatric surgery for morbid obesity
Eric J. DeMaria
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease
S Klein et al.
GASTROENTEROLOGY (2006)
Non-alcoholic steatohepatitis: Effect of Roux-en-Y gastric bypass surgery
KB Barker et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
JG Kral et al.
SURGERY (2004)
分享论文
